HHC
CLVS

Hutchin Hill Capital’s Clovis Oncology, Inc. CLVS Stock Holding History

Hutchin Hill Capital’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-14,500
Closed -$971K – 607
2013
Q2 		$971K Buy
+14,500
New +$652K 0.1% 125

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hutchin Hill Capital's CLVS Position: Q3 2013 in Review

Hutchin Hill Capital sold out of Clovis Oncology, Inc. (CLVS) in Q3 2013, closing a stake of 14,500 shares — an estimated $971K sold.

Hutchin Hill Capital first reported a position in CLVS in Q2 2013 and held it in 1 quarter. The position peaked at $971K in Q2 2013. 116 funds tracked by Wall St. Rank hold CLVS as of Q3 2013.

  • Hutchin Hill Capital reported no remaining Clovis Oncology, Inc. position as of Q3 2013 after selling out during the quarter.
  • Hutchin Hill Capital sold 14,500 Clovis Oncology, Inc. shares in Q3 2013, an estimated $971K.
  • Hutchin Hill Capital first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 1 quarter.
  • Hutchin Hill Capital's Clovis Oncology, Inc. position peaked at $971K in Q2 2013.
  • 116 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2013.

Based on Hutchin Hill Capital's 13F filing for Q3 2013, filed 14 Nov 2013.